cancer immunotherapy

AstraZeneca Might Outperform Merck, Bristol-Myers In Cancer Therapy Market
Bidness Etc.
Mon, 09/29/14 - 10:31 am
Merck
Bristol-Myers Squibb
AstraZeneca
MEDI4736
cancer immunotherapy
AstraZeneca steps up push into cancer immunotherapy
Yahoo/Reuters
Thu, 07/31/14 - 09:16 am
cancer immunotherapy
AstraZeneca
MEDI4736
Jounce Taps Merck Vet to Lead Cancer Drug Push
Motley Fool
Thu, 07/10/14 - 03:40 pm
Jounce Therapeutics
Merck
cancer immunotherapy
Pfizer's Plan B In Immuno-Oncology: Collaboration With Smaller Companies
Seeking Alpha
Wed, 06/25/14 - 05:16 pm
Pfizer
cancer immunotherapy
Cellectis
IPO Preview: Kite Pharma
Seeking Alpha
Fri, 06/20/14 - 09:39 am
IPOs
Kite Pharma
cancer immunotherapy
Pfizer signs cancer immunotherapy deal with France's Cellectis
Yahoo/Reuters
Wed, 06/18/14 - 04:22 am
Pfizer
France
Cellectis
cancer immunotherapy
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Yahoo/Benzinga
Thu, 06/5/14 - 12:04 pm
ASCO
cancer immunotherapy
Bristol-Myers Squibb
Yervoy
Merck
MK-3475
Immune Therapy’s Cancer Promise Creates Research Rush
Bloomberg
Thu, 05/29/14 - 08:52 am
cancer immunotherapy
Merck
MK-3475
Roche
Yervoy
Bristol-Myers Squibb
Merck KGaA
AstraZeneca
Bristol, Celldex Collaborating on Cancer Immunotherapy Study
TheStreet.com
Wed, 05/14/14 - 09:10 am
cancer immunotherapy
Celldex
Bristol-Myers Squibb
Innate Pharma And The Role Of The Innate Immune System In Cancer Immunotherapy
Seeking Alpha
Thu, 05/1/14 - 08:39 am
Innate Pharma S.A.
cancer immunotherapy
Glaxo’s Immunotherapy Fails to Help Lung Cancer Patients
Bloomberg
Thu, 03/20/14 - 07:10 am
GSK
cancer immunotherapy
MAGE-A3
non-small cell lung cancer
Should You Believe Tesaro's Hype?
Motley Fool
Mon, 03/17/14 - 05:00 pm
Tesaro
rolapitant
AnaptysBio
cancer immunotherapy
Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Fierce Biotech
Mon, 03/17/14 - 10:53 am
MK-3475
Merck
Five Prime
cancer immunotherapy
Bristol-Myers Squibb
Tesaro pays $17M to team with AnaptysBio on cancer immunotherapies
Fierce Biotech
Thu, 03/13/14 - 08:34 am
Tesaro
AnaptysBio
cancer immunotherapy
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wed, 02/12/14 - 09:14 am
cancer immunotherapy
Merck
Bristol-Myers Squibb
Amgen
Incyte
Pfizer
MK-3475
Ablynx
Yervoy
Merck Accelerates Cancer-Immunotherapy Program With Three Collaborations
TheStreet.com
Wed, 02/5/14 - 08:42 am
cancer immunotherapy
Merck
Amgen
Incyte
Pfizer
Bristol-Myers Squibb
MK-3475
Focus On Cancer Immunotherapy Results
Seeking Alpha
Sat, 01/25/14 - 10:58 am
cancer immunotherapy
ImmunoCellular Therapeutics
ICT-107
DCVax®-L
Northwest Biotherapeutics
Cancer immunotherapies set to storm onto the market, analysts say
Fierce Biotech
Wed, 10/16/13 - 10:03 am
cancer immunotherapy
Merck
Roche
Bristol-Myers Squibb
Cancer immunotherapies turn a corner in race to megablockbuster market
Fierce Biotech
Wed, 10/2/13 - 10:54 am
cancer immunotherapy
Merck
MK-3475
nivolumab
Bristol-Myers Squibb
Roche
MPDL3280A
PDL-1
MacroGenics trumpets cancer immunotherapies in $60M IPO pitch
Fierce Biotech
Thu, 09/5/13 - 08:56 am
Macrogenics
cancer immunotherapy
IPOs

Pages